Earnings Overview#
Westlake Chemical Corporation faced a challenging start to 2026, reporting a significant earnings miss for the first quarter. The company recorded an earnings per share (EPS) of -$0.77, which was much lower than the anticipated -$0.17. This resulted in a staggering 352.94% negative surprise. Additionally, revenue came in at $2.65 billion, falling short of the expected $2.78 billion.
Key Financial Metrics#
In Q1 2026, Westlake reported a net loss of $100 million, a notable increase from a $33 million loss in the same quarter last year. The gross profit margin stood at only 7.3%, indicating ongoing challenges in profitability. Factors contributing to this decline included a $67 million legal settlement and $18 million in expenses related to shutdowns. Here are some key financial highlights: - Revenue: $2.65 billion, down 4.68% from forecast - EPS: -$0.77, significantly lower than -$0.17 forecast - Total EBITDA: $235 million - Cash and Investments: $2.5 billion - Total Debt: $5.6 billion
Market Reaction#
Following the disappointing earnings report, Westlake's stock price dropped by 11.25% in pre-market trading, bringing shares down to $101.95. This decline is particularly notable given the stock's impressive 77% increase over the past six months. Analysts suggest that the stock may be overvalued compared to its fair value, as it has fluctuated between $56.33 and $124.23 over the past year.
Future Outlook#
Looking ahead, Westlake aims to improve its earnings before interest, taxes, depreciation, and amortization (EBITDA) by $600 million in 2026 through cost-saving measures and operational enhancements. The company projects an EPS of $1.55 for Q2 2026 and $3.78 for the full year of 2027. Management remains optimistic about overcoming temporary challenges, including the impact of rising natural gas prices, which negatively affected EBITDA by $45 million in Q1 2026.